期刊文献+

人肿瘤坏死因子-α基因转染对舌癌细胞的抑制作用 被引量:2

Suppression Effect of Human Tumor Necrosis Factor-α Gene Transfection on Tongue Carcinoma Cells
下载PDF
导出
摘要 目的 :探讨人肿瘤坏死因子_α(hTNF_α)基因转染对舌癌细胞生长的影响。方法 :制备和纯化含hTNF_α基因的穿梭质粒 ,用DOSPER阳离子脂质体介导转染Tca8113舌癌细胞 ,对照组只给予等量的脂质体 ,不加入质粒 ;转染基因 2 4、4 8、72、92h后用ELISA法检测细胞培养上清液中hTNF_α的浓度 ,并用MTT法检测细胞的存活率。结果 :基因转染 2 4、4 8、72、96h后转染组与对照组细胞培养上清液中hTNF_α浓度之间的差异均有显著性 (P <0 0 5 ) ,转染组各个时期浓度均高于对照组 ;MTT法检测相应各时期转染组与对照组平均OD值之间的差异均有显著性 (P <0 0 5 ) ,转染组各个时期平均OD值均低于对照组 ,转染细胞的存活率降低 ,生长受抑制。结论 Objective: The aim of this study was to investigate suppression effects of the transfection of human tumor necrosis factor_α (hTNF_α) gene on tongue carcinoma cells.Methods: The shuttle plasmid containing hTNF_α gene was extracted and purified, then it was transferred into Tca8113 tongue carcinoma cells with cationic liposome DOSPER. The control group was only given equivalent liposomes, except the plasmid. After culturing for 24, 48, 72 and 96 hours, the expression of hTNF_α gene in Tca8113 cells was analyzed by ELISA and, the survival rate of transferred cells was assayed by MTT enzymatic labeling technique.Results: The transferred Tca8113 cells displayed significantly overexpression of hTNF_α (P<0.05). The survival rate of the transferred Tca8113 cells was decreased significantly (P<0.05).Conclusion: Transfection of hTNF_α gene in vitro mediated by cationic liposomes can induce the overexpression of hTNF_α and inhibit the growth of tongue carcinoma cells.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2002年第1期52-54,共3页 West China Journal of Stomatology
基金 卫生厅科学研究基金资助项目 (编号 960 0 3 9)
关键词 人肿瘤坏死因子-Α 舌癌 基因转染 阳离子脂质体 癌细胞 抑制作用 human tumor necrosis factor_α tongue carcinoma gene transfection cationic liposome
  • 相关文献

参考文献10

  • 1Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced sorum factor that cause necrosis of tumors. Proc Natl Acad Sci USA, 1975, 72(9): 3666 - 3670 被引量:1
  • 2Budd GT, Green S, Baker LH, et al. A Southwest oncology group:Phase Ⅱ trail of recombinant tumor necrosis fator in metastatic breast cancer. Cancer, 1991, 68(8): 1694 ~ 1695 被引量:1
  • 3Sambrxxok J,Fritsch EF,Maniatis T,著.金冬雁,黎孟枫,译.分子克隆实验指南.第2版,北京:科学出版社,1992:24~27 被引量:1
  • 4程金科,林晨,牟巨伟,张雪艳,邢嵘,吴旻.野生型p53基因重组体腺病毒介导的肿瘤抑制作用[J].自然科学进展(国家重点实验室通讯),1999,9(6):505-511. 被引量:7
  • 5Helson L, Green S, Carswell E, et al. Effect of tumor necrosis factor on cultured human melanoma cells. Nature, 1975, 258(5537): 731 - 732 被引量:1
  • 6Alexander HR, Bartlett DL, Libutti SK, et al. Isolated hepatic peffusion with tumor necrosis factor and melphalan for unresectable cancer confined to the liver. J Clin Oncol, 1998, 16(4):1479 ~ 1489 被引量:1
  • 7Cao G, Kuriyama S, Du P, et al. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor α gene transfer. Gastroenterology, 1997, 112(2): 501 -510 被引量:1
  • 8Hwu P, Yannelli J, Kriegler M, et al. Functional and molecular characterization of tumor-infiltrating lyphocytes transduced with tumor necrosis factor-α cDNA for the gene therapy of cancer in humans. J Immunol, 1993, 150(9): 4104~4115 被引量:1
  • 9Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature, 1997,389 (6648): 239-242 被引量:1
  • 10Scheule RK. Gene therapy lung cancer-an application for cationic lipid-mediated gene delivery. J Natl Cancer Inst, 1998, 90(15):1118 被引量:1

共引文献6

同被引文献16

  • 1Asher A, Mule J J, Reichert CM, et al. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol, 1987,138(3) :963 - 974 被引量:1
  • 2Sugarman BJ, Aggarwal BB, Hass PE, et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science, 1985, 230(4728) :943 ~945 被引量:1
  • 3Budd GT, Green S, Baker LH, et al. A southwest oncology group: Phase Ⅱ trail of recombinant tumor necrosis factor in metastatic breast cancer. Cancer, 1991, 68(8): 1694 ~ 1695 被引量:1
  • 4Agah R, Malloy B, Sherrod A, et al. Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice. Cancer Res, 1988,48(8) :2245 被引量:1
  • 5Rubin SC, Hoskins WJ, Markman M, et al. Synergistic activity of tumor necrosis factor and interferon in a nude mouse model of human ovarian cancer. Gynecol Oncol, 1989, 34(3): 353 被引量:1
  • 6Suk K, Chang I, Kim YH, et al. Interferon gamma (IFN gamma) and tumor necrosis factor alpha synergism in ME~180 cervical cancer cell apoptesis and necrosis. J Biol Chem,2001,276(16):13153- 13159 被引量:1
  • 7Lewis GD, Aggarwal BB, Eessalu TE, et al. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma. Cancer Res, 1987, 47(20):5382~5385 被引量:1
  • 8Balkwill FR, Lee A, Aldam G, et al. Hunan tumor xenografts treated with recombined human tumor necrosis factor alone or in combinafon with intefferons. Cancer Res, 1986, 46(8): 3990 被引量:1
  • 9Creaey AA, Barhtolomew JC, Merigan IC. The importance of Go, in the site of action of interferon in the cell cycle. Exp Cell Res, 1981, 134(1): 155~ 160 被引量:1
  • 10Jiang H, Stewart CA, Fast DJ, et al. Tumor-derived recognition factor (TDRF)induces production of TNF-alpha by murine macrophages, but requires synergy with IFN-gamma alone or in combination with IL-2 to induce nitric oxide synthase. Int J Immunopharmacol, 1996, 18(8-9): 479~490 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部